Nicholas Finn

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Real-World Benefit of Nivolumab in A Canadian Non-Small-Cell Lung Cancer Cohort

Rosalyn A. Juergens, Caroline Mariano, Jacques Jolivet et al. · Current Oncology · 2018 · 57 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

Rebecca Starkman, Shabbir M.H. Alibhai, Richard A. Wells et al. · Leukemia · 2019 · 34 citations

Medicine, Clinical Sciences, Geriatric Medicine +17

Peptide-Affinity Precipitation of Extracellular Vesicles and Cell-Free DNA Improves Sequencing Performance for the Detection of Pathogenic Mutations in Lung Cancer Patient Plasma

Simi Chacko, Michelle Davey, Jacynthe Lacroix et al. · International Journal of Molecular Sciences · 2020 · 24 citations · Full text

Medicine, Molecular Biology, Oncology +17

P2.07-029 CheckMate 169: Safety/Efficacy of Nivolumab in Canadian Pretreated Advanced NSCLC (including Elderly and PS 2) Patients

Rosalyn A. Juergens, Quincy S. Chu, J. Rothenstein et al. · Journal of Thoracic Oncology · 2017 · 15 citations

Medicine, Geriatric Medicine, Pharmacotherapy +3